Telomere length, frailty and death

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Pivotal study finds that telomere length lacks association with aging, yet frailty reflects mortality.

It is no secret that global populations demographics are aging significantly [1]. While the economic burden on younger adults to support the aging populations is a growing concern, it is important to note that the age of an individual is not reflective of their productivity in society [2]. So let’s talk telomere length (again):

Longevity.Technology: Chronological age reflects the time someone has lived since birth. Functional age, like biological age, is a concept describing the biological condition of tissues, organs and thus reflecting life expectancy. One proposed clinical biomarker studied in Longevity research is telomere length (TL). Telomeres have been a research focus, but perhaps, as some papers show, frailty is a better yardstick for Longevity.

Telomeres are protective DNA caps at the ends of every chromosome that slowly erode with age due to shortfalls of cellular replication machinery. A simple literature search however will reveal conflicting stances on the relevance of TL as an aging indicator.

Frailty is defined as a multi-systemic syndrome where there is a decrease in functionality, increased vulnerability to stress factors and increased risk of aging diseases. This is a well-establish marker for aging and mortality, and thus is accepted in the Longevity field.

Frailty is often measured by frailty phenotype (FP) proposed by the Cardiovascular Heart Study. Some characteristics include unintentional weight-loss of 4.5kg a year, exhaustion, weakness, slow walking speed, &c.

The relationship between TL and frailty remains unclear; on one hand, a 2018 study by Rosas-Vargas et al found a strong statistical correlation between frailty and TL in both males and females in a 323 Mexican cohort [3]. In contrast, similar studies in China did not find any correlation between the two factors [4].

Ovarian Longevity webinar

Interestingly, a German study that did not find TL and frailty correlations found instead that epigenetics, frailty and senescence are closely related [5].

To clarify these conflicting reports, Professor Leocardio Rodriguez-Mañas and his team at the Hospital Universitario de Getafe evaluated whether or not TL has an association with frailty and mortality based on a Spanish community.

It is important to note that this was both a cross-sectional and longitudinal study, meaning it included a large sample of different individuals who were followed up with after a mean of 3.5 years. Additionally, two cohorts were analysed separately using the same parameters and adjustments, yielding the same conclusion based on meta-analysis.

 


 

“No association was found between TL and frailty or mortality … however, strong inverse correlation was found between frailty and mortality.”

 


 

Blood samples were analysed to calculate TL and physical performance was evaluated to determine FP according to CHS guidelines along with surveys on how an individual felt. No association was found between TL and frailty or mortality, even after age and sex statistical adjustments. However, strong inverse correlation was found between frailty and mortality [6].

While the results are quite definitive, the authors acknowledge that differences in study methodologies, as well as gender, age, demographic and socio-economic distributions may affect TL in ways that are not yet understood.

Ovarian Longevity webinar

However, the study’s findings suggest that “in the elderly, telomere length is not especially worthy, assessed in terms of both physical function and longevity.” Better methods of reflecting functional age must be found to boost Longevity of individuals, in order to benefit society and quality of life.

[1] https://www.nber.org/digest/jul11/implications-population-aging-economic-growth
[2] https://hbr.org/2014/01/the-truth-about-aging-populations
[3] https://pubmed.ncbi.nlm.nih.gov/29989281/
[4] https://www.sciencedirect.com/science/article/pii/S0047637415300191
[5] https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-016-0186-5
[6] https://link.springer.com/article/10.1007/s11357-020-00291-0

 

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Smartphone-sized bioartificial kidney prototype passes key test

The Kidney Project successfully tests a prototype bioartificial kidney and wins KidneyX’s $650,000 Artificial Kidney Prize. The Kidney Project’s implantable bioartificial kidney, one that promises...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming therapies for rejuvenation. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the...

Senolytic cocktail reduces aging-associated disc degeneration

Senolytic drug therapies that target aging cells early pave the way to easing back pain. New findings, reported in Nature Communications, show how a novel...
Nutriop